Form 4: Orchestra BioMed Holdings Executive Sells Shares to Cover Tax Obligations

Darren Sherman, President and COO of Orchestra BioMed Holdings, sold 31,815 shares to cover tax obligations related to vesting restricted stock units.

Summary

• Darren Sherman, the President and Chief Operating Officer of Orchestra BioMed Holdings, sold 31,815 shares of common stock on December 5, 2024.
• The sale was executed at a price of $5.57 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Sherman directly owns 733,972 shares of Orchestra BioMed Holdings common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The sale of 31,815 shares is not unusual for an executive at this level, and the price of $5.57 is consistent with the market price at the time of the transaction.
• Similar transactions are regularly reported by executives at comparable companies.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale for tax purposes.

Key Dates

Keywords

Orchestra BioMed Holdings, Darren Sherman, stock sale, Form 4, insider trading, restricted stock units, tax obligations